Ajanta Pharma Board nod for ₹315 cr share buyback
[ad_1] Drugmaker Ajanta Pharma’s board of directors has approved a ₹315 crore share buyback proposal of the company. The company has proposed buyback, through the tender offer process, of 22,10,500 equity shares of face value of ₹2 each at a price of ₹1,425 per share. It said the total pay-out towards the buyback will not […]
Continue Reading